AMLX
Price
$13.10
Change
+$0.03 (+0.23%)
Updated
Dec 12 closing price
Capitalization
1.44B
109 days until earnings call
Intraday BUY SELL Signals
TARA
Price
$5.70
Change
-$0.31 (-5.16%)
Updated
Dec 12 closing price
Capitalization
294.3M
88 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AMLX vs TARA

Header iconAMLX vs TARA Comparison
Open Charts AMLX vs TARABanner chart's image
Amylyx Pharmaceuticals
Price$13.10
Change+$0.03 (+0.23%)
Volume$829.8K
Capitalization1.44B
Protara Therapeutics
Price$5.70
Change-$0.31 (-5.16%)
Volume$700.49K
Capitalization294.3M
AMLX vs TARA Comparison Chart in %
AMLX
Daily Signal:
Gain/Loss:
TARA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Moderna (NASDAQ:MRNA), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Sarepta Therapeutics (NASDAQ:SRPT), Nektar Therapeutics (NASDAQ:NKTR), Novavax (NASDAQ:NVAX), Inovio Pharmaceuticals (NASDAQ:INO).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.21B. The market cap for tickers in the group ranges from 58 to 114.69B. VRTX holds the highest valuation in this group at 114.69B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 1%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was 65%. NBY experienced the highest price growth at 158%, while BPTSY experienced the biggest fall at -99%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -11%. For the same stocks of the Industry, the average monthly volume growth was -7% and the average quarterly volume growth was 72%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 80
Price Growth Rating: 54
SMR Rating: 92
Profit Risk Rating: 93
Seasonality Score: 17 (-100 ... +100)

Market Cap

The average market capitalization across the group is 872.82M. The market cap for tickers in the group ranges from 310.3M to 1.44B. AMLX holds the highest valuation in this group at 1.44B. The lowest valued company is TARA at 310.3M.

High and low price notable news

The average weekly price growth across all stocks in the group was -11%. For the same group, the average monthly price growth was 8%, and the average quarterly price growth was 114%. AMLX experienced the highest price growth at -10%, while TARA experienced the biggest fall at -13%.

Volume

The average weekly volume growth across all stocks in the group was 130%. For the same stocks of the group, the average monthly volume growth was 79% and the average quarterly volume growth was 504%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 31
P/E Growth Rating: 100
Price Growth Rating: 36
SMR Rating: 97
Profit Risk Rating: 100
Seasonality Score: 50 (-100 ... +100)
VS
AMLX vs. TARA commentary
Dec 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Buy and TARA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 13, 2025
Stock price -- (AMLX: $13.07 vs. TARA: $6.01)
Brand notoriety: AMLX and TARA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 120% vs. TARA: 211%
Market capitalization -- AMLX: $1.44B vs. TARA: $294.3M
AMLX [@Biotechnology] is valued at $1.44B. TARA’s [@Biotechnology] market capitalization is $294.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileTARA’s FA Score has 1 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • TARA’s FA Score: 1 green, 4 red.
According to our system of comparison, both AMLX and TARA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 4 TA indicator(s) are bullish while TARA’s TA Score has 3 bullish TA indicator(s).

  • AMLX’s TA Score: 4 bullish, 6 bearish.
  • TARA’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, AMLX is a better buy in the short-term than TARA.

Price Growth

AMLX (@Biotechnology) experienced а -9.80% price change this week, while TARA (@Biotechnology) price change was -12.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.68%. For the same industry, the average monthly price growth was +4.10%, and the average quarterly price growth was +64.61%.

Reported Earning Dates

AMLX is expected to report earnings on Apr 01, 2026.

TARA is expected to report earnings on Mar 11, 2026.

Industries' Descriptions

@Biotechnology (+0.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX($1.44B) has a higher market cap than TARA($294M). AMLX YTD gains are higher at: 245.767 vs. TARA (13.826). TARA has higher annual earnings (EBITDA): -59.43M vs. AMLX (-156.76M). AMLX has more cash in the bank: 344M vs. TARA (133M). TARA has less debt than AMLX: TARA (3.66M) vs AMLX (5.94M). TARA has higher revenues than AMLX: TARA (0) vs AMLX (-665K).
AMLXTARAAMLX / TARA
Capitalization1.44B294M489%
EBITDA-156.76M-59.43M264%
Gain YTD245.76713.8261,778%
P/E Ratio2.69N/A-
Revenue-665K0-
Total Cash344M133M259%
Total Debt5.94M3.66M162%
FUNDAMENTALS RATINGS
TARA: Fundamental Ratings
TARA
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMLXTARA
RSI
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
88%
Momentum
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 10 days ago
79%
Bullish Trend 5 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 16 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
80%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AMLX
Daily Signal:
Gain/Loss:
TARA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NWALX39.140.35
+0.90%
Nationwide BNY Mellon Dyn US Eq Inc A
RSVAX26.540.21
+0.80%
Victory RS Value A
SIIAX16.420.03
+0.18%
AlphaCentric Real Income A
EIVAX15.51N/A
N/A
Allspring Special Large Cap Value A
ODVIX33.49-14.83
-30.69%
Invesco Developing Markets R6

TARA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TARA has been loosely correlated with RGNX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TARA jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TARA
1D Price
Change %
TARA100%
+4.70%
RGNX - TARA
41%
Loosely correlated
-1.61%
SYRE - TARA
41%
Loosely correlated
-0.87%
AMLX - TARA
40%
Loosely correlated
-1.21%
DNLI - TARA
39%
Loosely correlated
-1.14%
TBPH - TARA
38%
Loosely correlated
+0.40%
More